Logo image of IPGP

IPG PHOTONICS CORP (IPGP) Stock Fundamental Analysis

USA - NASDAQ:IPGP - US44980X1090 - Common Stock

84.66 USD
+3.41 (+4.2%)
Last: 10/3/2025, 8:00:02 PM
84.66 USD
0 (0%)
After Hours: 10/3/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, IPGP scores 4 out of 10 in our fundamental rating. IPGP was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While IPGP has a great health rating, there are worries on its profitability. IPGP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year IPGP was profitable.
IPGP had a positive operating cash flow in the past year.
Of the past 5 years IPGP 4 years were profitable.
In the past 5 years IPGP always reported a positive cash flow from operatings.
IPGP Yearly Net Income VS EBIT VS OCF VS FCFIPGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a Return On Assets value of -9.05%, IPGP is not doing good in the industry: 62.90% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -10.24%, IPGP is doing worse than 61.29% of the companies in the same industry.
Industry RankSector Rank
ROA -9.05%
ROE -10.24%
ROIC N/A
ROA(3y)1.4%
ROA(5y)3.68%
ROE(3y)1.57%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
IPGP Yearly ROA, ROE, ROICIPGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

IPGP's Operating Margin has declined in the last couple of years.
IPGP has a Gross Margin (34.65%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of IPGP has declined.
IPGP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.65%
OM growth 3Y-60.56%
OM growth 5Y-41.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-5.58%
IPGP Yearly Profit, Operating, Gross MarginsIPGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

9

2. Health

2.1 Basic Checks

IPGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IPGP has been reduced compared to 1 year ago.
The number of shares outstanding for IPGP has been reduced compared to 5 years ago.
There is no outstanding debt for IPGP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IPGP Yearly Shares OutstandingIPGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IPGP Yearly Total Debt VS Total AssetsIPGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 10.37 indicates that IPGP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 10.37, IPGP belongs to the best of the industry, outperforming 87.90% of the companies in the same industry.
There is no outstanding debt for IPGP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.37
ROIC/WACCN/A
WACC9.11%
IPGP Yearly LT Debt VS Equity VS FCFIPGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

IPGP has a Current Ratio of 6.79. This indicates that IPGP is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IPGP (6.79) is better than 90.32% of its industry peers.
IPGP has a Quick Ratio of 5.39. This indicates that IPGP is financially healthy and has no problem in meeting its short term obligations.
IPGP has a better Quick ratio (5.39) than 87.90% of its industry peers.
Industry RankSector Rank
Current Ratio 6.79
Quick Ratio 5.39
IPGP Yearly Current Assets VS Current LiabilitesIPGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

The earnings per share for IPGP have decreased strongly by -76.16% in the last year.
The earnings per share for IPGP have been decreasing by -19.50% on average. This is quite bad
IPGP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.77%.
IPGP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.76% yearly.
EPS 1Y (TTM)-76.16%
EPS 3Y-34.65%
EPS 5Y-19.5%
EPS Q2Q%-64.44%
Revenue 1Y (TTM)-14.77%
Revenue growth 3Y-12.55%
Revenue growth 5Y-5.76%
Sales Q2Q%-2.69%

3.2 Future

The Earnings Per Share is expected to grow by 17.39% on average over the next years. This is quite good.
IPGP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.17% yearly.
EPS Next Y-51.79%
EPS Next 2Y4.34%
EPS Next 3Y17.39%
EPS Next 5YN/A
Revenue Next Year-1.15%
Revenue Next 2Y2.95%
Revenue Next 3Y3.83%
Revenue Next 5Y7.17%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IPGP Yearly Revenue VS EstimatesIPGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
IPGP Yearly EPS VS EstimatesIPGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 117.58, which means the current valuation is very expensive for IPGP.
Compared to the rest of the industry, the Price/Earnings ratio of IPGP is on the same level as its industry peers.
When comparing the Price/Earnings ratio of IPGP to the average of the S&P500 Index (27.86), we can say IPGP is valued expensively.
With a Price/Forward Earnings ratio of 54.01, IPGP can be considered very expensive at the moment.
IPGP's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.32. IPGP is valued rather expensively when compared to this.
Industry RankSector Rank
PE 117.58
Fwd PE 54.01
IPGP Price Earnings VS Forward Price EarningsIPGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

IPGP's Enterprise Value to EBITDA ratio is in line with the industry average.
IPGP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.3
EV/EBITDA 39.23
IPGP Per share dataIPGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as IPGP's earnings are expected to grow with 17.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.34%
EPS Next 3Y17.39%

0

5. Dividend

5.1 Amount

IPGP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IPG PHOTONICS CORP

NASDAQ:IPGP (10/3/2025, 8:00:02 PM)

After market: 84.66 0 (0%)

84.66

+3.41 (+4.2%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners70.07%
Inst Owner Change0%
Ins Owners6.4%
Ins Owner Change-0.84%
Market Cap3.57B
Analysts72.5
Price Target81.8 (-3.38%)
Short Float %9.64%
Short Ratio9.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.22%
Min EPS beat(2)-57.53%
Max EPS beat(2)69.97%
EPS beat(4)2
Avg EPS beat(4)11.01%
Min EPS beat(4)-57.53%
Max EPS beat(4)69.97%
EPS beat(8)4
Avg EPS beat(8)5.09%
EPS beat(12)8
Avg EPS beat(12)8.18%
EPS beat(16)10
Avg EPS beat(16)8.23%
Revenue beat(2)1
Avg Revenue beat(2)2.7%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)7.06%
Revenue beat(4)3
Avg Revenue beat(4)1.68%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)7.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.25%
Revenue beat(12)6
Avg Revenue beat(12)-0.61%
Revenue beat(16)9
Avg Revenue beat(16)0.1%
PT rev (1m)0%
PT rev (3m)20.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.04%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-27.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.82%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)2.46%
Valuation
Industry RankSector Rank
PE 117.58
Fwd PE 54.01
P/S 3.78
P/FCF 55.3
P/OCF 23.66
P/B 1.7
P/tB 1.81
EV/EBITDA 39.23
EPS(TTM)0.72
EY0.85%
EPS(NY)1.57
Fwd EY1.85%
FCF(TTM)1.53
FCFY1.81%
OCF(TTM)3.58
OCFY4.23%
SpS22.41
BVpS49.85
TBVpS46.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.05%
ROE -10.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.65%
FCFM 6.83%
ROA(3y)1.4%
ROA(5y)3.68%
ROE(3y)1.57%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.46%
ROCE(5y)8.05%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-60.56%
OM growth 5Y-41.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-5.58%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 141.45%
Cap/Sales 9.14%
Interest Coverage N/A
Cash Conversion 277.64%
Profit Quality N/A
Current Ratio 6.79
Quick Ratio 5.39
Altman-Z 10.37
F-Score4
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)146.85%
Cap/Depr(5y)132.22%
Cap/Sales(3y)8.79%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.16%
EPS 3Y-34.65%
EPS 5Y-19.5%
EPS Q2Q%-64.44%
EPS Next Y-51.79%
EPS Next 2Y4.34%
EPS Next 3Y17.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.77%
Revenue growth 3Y-12.55%
Revenue growth 5Y-5.76%
Sales Q2Q%-2.69%
Revenue Next Year-1.15%
Revenue Next 2Y2.95%
Revenue Next 3Y3.83%
Revenue Next 5Y7.17%
EBIT growth 1Y-105.93%
EBIT growth 3Y-65.51%
EBIT growth 5Y-45.12%
EBIT Next Year158.96%
EBIT Next 3Y43.07%
EBIT Next 5Y28.3%
FCF growth 1Y-42.28%
FCF growth 3Y-17.56%
FCF growth 5Y-4.7%
OCF growth 1Y-31.73%
OCF growth 3Y-14%
OCF growth 5Y-5.18%